Further, although we used the AUA’s definition of biochemical recurrence that did not distinguish between rising PSA or additional treatment, we cannot fully hypothesize on the mechanisms how antidepressant use and depression influence prostate cancer outcomes; however, our application of this definition of biochemical recurrence has been applied in several publications [45–52]. This evidence concerns the gene KLK3 and major depressive disorder.